PET scan study for aggressive lymphoma patients
Part of Blood & lymphatic, Cancer clinical trials.
This study uses a special PET/CT scan to look at the environment around your lymphoma. The goal is to see if this scan can predict how well your treatment will work and your long-term outcome.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with an aggressive type of lymphoma.
- Your baseline PET/CT scan shows moderate to high FDG uptake (activity) in the lymphoma spots.
- You have not had any other cancers before.
- Your heart, liver, and kidneys are working normally.
- Your doctor expects you to live at least 6 months and you can complete follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new type of PET scan using a special tracer called Al18F-NOTA-FAPI-04 to see if it can better detect cancer, heart disease, or immune system conditions. The goal is to find out how well this imaging method works for diagnosis or monitoring of these diseases.
This study tests a new imaging agent that helps PET scans show cancer more clearly. It may help doctors see where cancer is in your body and plan your treatment better.
This study uses a special PET/CT scan to learn more about lymphoma in adults. The scan may help doctors better understand your cancer and guide treatment decisions.
This trial looks at whether PET/CT scans can better predict outcomes in people with fast-growing lymphoma. If you are newly diagnosed and receiving standard treatment, the study may help refine how response is evaluated.
This trial tests a PET scan (a type of imaging) that targets cells in the body that help support cancers. It may help doctors better see where cancer-associated cells are located, which could guide future cancer care.
This trial uses a special PET scan to take detailed pictures of slow-growing lymphomas, likely before or after your regular treatment scan. It may help your doctor see exactly where the lymphoma is in your body.
Hear when a new Aggressive Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.